Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)

Clinical trial NCT02779101 · UNKNOWN

Trial details

NCT number: NCT02779101
Sponsor: Prof. Dr. Matthias Preusser
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma

Start date: 2016-06-01
Primary completion: 2018-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.